bioanalytical support of biosimilars expect the unexpected
Published 3 years ago • 277 plays • Length 1:00:13Download video MP4
Download video MP3
Similar videos
-
54:18
clinical and bioanalytical aspects of immune monitoring via elispot
-
2:04
biosimilars: the path to approval
-
1:13
dr. cuellar on concerns with extrapolating data for biosimilars
-
1:00
dr. hershman on the equivalency of biosimilars and biologics
-
1:10
biosimilars: clinical data
-
1:28
fast facts about the quality of biosimilars – amgen science
-
46:16
antibody discovery by single b cell screening on beacon®
-
2:58
the next generation of biomanufacturing at amgen
-
6:48
pre diagnostics looks to early detection of alzheimer's
-
2:03
biosimiliars
-
8:03
biosimilars and biologics | patient preprheum
-
20:06
biologics and biosimilars: extrapolation of indications – information for healthcare providers
-
2:21
what are biosimilars?
-
1:25
what is a biosimilar?
-
35:31
understanding biosimilars: how the availability of biosimilars will impact clinical practice
-
0:50
barriers to complex biomolecular testing in europe
-
52:09
seeing through the mist: metabolite identification and profiling strategies
-
14:24
angiocrine bioscience
-
1:25
the role of machine learning in predicting avelumab efficacy in la/muc